Compumedics is a publicly traded Australian medical device company (ASX: CMP) that develops, manufactures, and commercializes diagnostic technology for sleep, brain, and ultrasonic blood-flow monitoring applications. Founded in 1987 by David Burton, the company acquired Neuroscan in 2002, the world's premier EEG and evoked potential system for neurological research. Compumedics also manufactures MEG (magnetoencephalography) brain imaging systems, with contracts at institutions including Barrow Neurological Institute. Annual revenue is AUD 50.3M. NASA selected Compumedics systems for Space Shuttle and ISS mission preparation.